Autonomic dysfunction associated with locked-in syndrome in a child

American Journal of Physical Medicine and Rehabilitation

Volumn 76, Issue 3, 1997, Pages 200-203

  Scott, Jane S ^a   Ockey, Robin R ^b   Holmes, Grace E ^c,d   Varghese, George ^c  

^a Tulsa Developmental Pediatrics   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Autonomic Dysfunction; Dopamine Agonist; Hypothalamic Storming; Locked In Syndrome

Indexed keywords

DRUG PRODUCTS; DRUG THERAPY; PEDIATRICS;

AUTONOMIC DYSFUNCTION; CARBIDOPA; HYDROCEPHALUS; HYPOTHALAMIC STORMING; LEVODOPA; LOCKED IN SYNDROME;

NEUROLOGY;

BROMOCRIPTINE; CARBIDOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HYDROCEPHALUS; LOCKED IN SYNDROME; MALE; PATHOGENESIS; TREATMENT OUTCOME;

AUTONOMIC NERVOUS SYSTEM DISEASES; BROMOCRIPTINE; CARBIDOPA; CHILD; DOPAMINE AGENTS; DOPAMINE AGONISTS; FEVER; HUMANS; HYDROCEPHALUS; HYPERTENSION; HYPERVENTILATION; HYPOTHALAMUS; MALE; MESENCEPHALON; QUADRIPLEGIA; SYNDROME; VENTRICULOPERITONEAL SHUNT;

EID: 0031148901     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002060-199705000-00007     Document Type: Article

References (40)

1. Rossitch E Jr, Bullard DE: The autonomic dysfunction syndrome: aetiology and treatment. Br J Neurosurg 1988;2:471-478.
2. Pranzatelli MR, Pavlakis SG, Gould RJ, De Vivo DC: Hypothalamic-midbrain dysregulation syndrome. hypertension, hyperthermia, hyperventilation, and decerebration. J Child Neurol 1991;6:115-122.
3. Penfield W: Diencephalic autonomic epilepsy. Arch Neurol Psychiatry 1929;22:358-374.
4. Penfield W, Jasper H: Epilepsy and the Functional Anatomy of the Human Brain. Boston, Little, Brown, 1954.
5. Soloman GE: Diencephalic autonomic epilepsy caused by a neoplasm. J Pediatr 1973;83:277-280.
6. Low PA: Clinical Autonomic Disorders. Boston, Little, Brown, 1943, p 466.
7. Bullard DE: Diencephalic seizures: responsiveness to bromocriptine and morphine. Ann Neurol 1987,21:609-611.
8. Talman WT, Florek G, Bullard DE: A hyperthermic syndrome in two subjects with acute hydrocephalus. Arch Neurol 1988;45:1037-1040.
9. Simpson RK, Fischer DK, Ehni BL: Neurogenic hyperthermia in subarachnoid hemorrhage. South Med J 1989;82.1577-1578.
10. Fox RH, Wilkins DC, Bell JA, et al.: Spontaneous periodic hypothermia: diencephalic epilepsy BMJ 1973;2:693-695.
11. Ockey RR, Mowry D, Varghese G: Use of Sinemet in locked-in syndrome: a report of two cases. Arch Phys Med Rehabil 1995;76:868-870.
12. Cherington M, Stears J, Hodges J: Locked-in syndrome caused by a tumor. Neurology 1976;26:180-182.
13. Katz RT, Haig AJ, Clark BB, et al.: Long-term survival, prognosis and life-care planning for 29 patients with chronic locked-in syndrome. Neurosurgery 1981;73:403-408.
14. Khurana RK, Genut AA, Yannakakis GD: Locked-in syndrome with recovery. Ann Neurol 1980;8:439-441.
15. Ohry A: The locked-in syndrome and related stated. Paraplegia 1981;28:73-75.
16. Patterson JR, Grabois M: Locked-in syndrome: a review of 139 cases. Stroke 1986;17:758-764.
17. Rao N, Costa JL: Recovery in non-vascular locked-in syndrome during treatment with Sinemet. Brain Inj 1989;3:207-211.
18. Plum F, Posner JB: The Diagnosis of Stupor and Coma. Philadelphia: FA Davis, 1996.
19. Bauer G, Gerstenbrand F, Rumpl E: Varieties of the locked-in syndrome J Neurol 1979;221:77-91.
20. Jacome DF, Morilla-Pastor D. Unreactive EEG: pattern in locked-in syndrome. Clin Electroencephalogr 1990;21:31-36.
21. Engel GL, Aring CD: Hypothalamic attacks with thalamic lesion. I. Physiologic and psychologic considerations. Arch Neurol Psych 1945;54:37-43.
22. Aring CD, Engel GL: Hypothalamic attacks with thalamic lesion. II. Anatomic consideration. Arch Neurol Psych 1945;54: 44-50.
23. Carmel PW: Vegetative dysfunctions of the hypothalamus. Acta Neurochir 1985;75:113-121.
24. Corbett SW, Kaufman LN, Keesey RE: Effects of betaadrenergic blockade on lateral hypothalamic lesion-induced thermogenesis. Am J Physiol 1983;245:E535-E541.
25. Hackenberry LE, Miner MF, Rea GL, et al.: Biochemical evidence of myocardial injury after severe head trauma. Crit Care Med 1982;10:641-644.
26. Clifton GL, McCormick WF, Grossman RG: Neuropathology of early and late deaths after head injury. Neurosurgery 1981;8:309-314.
27. Melville KI, Blum B, Shister HE, et al.: Cardiac ischemic changes and arrhythmias induced by hypothalamic stimulation. Am J Cardiol 1963;12:781-791.
28. Reichenbach DD, Benditt EP: Catecholamines and cardiomyopathy: the pathogensis and potential importance of myofibrillar degeneration. Hum Pathol 1970;1:125-150.
29. Neil-Dwyer G, Walter P, Cruickshank JM, et al.: Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage BMJ 1978;ii:990-992.
30. Robertson CS, Clifton GL, Taylor AA, et al.: Treatment of hypertension associated with head injury. J Neurosurg 1983;59: 455-460.
31. Meythaler JM, Stinson AM: Fever of central origin in traumatic brain injury controlled with propranolol. Arch Phys Med Rehabil 1994;75:816-818.
32. Brooke MM, Patterson DR, Questad KA, et al.: The treatment of agitation during initial hospitalization after traumatic brain injury. Arch Phys Med Rehabil 1992;73:917-921.
33. Ratey JJ, Morrill R, Oxenkrug G: Use of propranolol for provoked and unprovoked episodes of rage. Am J Psychiatry 1983;140:1356-1357.
34. Yudofsk S, Williams D, Gorman J: Propranolol in the treatment of rage and violent behavior in patients with chronic brain syndromes. Am J Psychiatry 1981;138:218-220.
35. Lasser NL, Nash J, Lasser VI, et al.: Effects of antihypertensive therapy on blood pressure control, cognition, and reactivity. Am J Med 1989;86:98-103.
36. Rogers TK, Bowman CE: Cognitive impairment associated with beta-blockade in the elderly. Postgard Med J 1990;66:1050-1052.
37. Greenblatt DJ, Scavone JM, Harmatz JS, et al.: Cognitvie effect of β-adrenergic antagonists after single doses: pharmacokinetics and pharmacodynamics of propranolol, atenolol, lorazepam, and placebo. Clin Pharmacol Ther 1993;53:577-584.
38. Wurzelmann J, Frishman WH, Aronson M, et al.: Neuropsychological effects of antihypertensive drugs. Cardiol Clin 1987;5: 689-701.
39. Palac DM, Cornish RD, McDonald WJ, et al.: Cognitive function in hypertensives treated with atenolol or propranolol. J Gen Intern Med 1990;5:310-318.
40. Baldessarini RJ: Drugs and the treatment of psychiatric disorders, in Goodman & Gilman, The Pharmacological Basis of Therapeutics, ed 9. New York, McGraw-Hill, 1996.